| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Darlene A. Monlish | |
| Laura G. Schuettpelz | |||
| Sima T. Bhatt | |||
| P2860 | cites work | Discrimination of bacterial lipoproteins by Toll-like receptor 6 | Q24291383 |
| Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3... | Q24297037 | ||
| Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins | Q24300005 | ||
| Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells | Q24658240 | ||
| Human lung cancer cells express functionally active Toll-like receptor 9 | Q24802960 | ||
| Unraveling the Pathogenesis of MDS: The NLRP3 Inflammasome and Pyroptosis Drive the MDS Phenotype | Q26744481 | ||
| Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and management | Q26796240 | ||
| Deconstructing innate immune signaling in myelodysplastic syndromes | Q26991974 | ||
| Bone marrow dendritic cell progenitors sense pathogens via Toll-like receptors and subsequently migrate to inflamed lymph nodes | Q57194638 | ||
| 'TaiLoRing' the response of dendritic cells to pathogens | Q57275464 | ||
| Association study of a functional Toll-like receptor 4 polymorphism with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma | Q57569182 | ||
| The roles of adoptive and active forms of immunotherapy in the cure of children suffering from acute lymphoid leukemia: a) underestimation of active immunotherapy benefit, b) its immunogenetic indications to select sensitive patients, hence prevent | Q77429957 | ||
| Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow | Q78460549 | ||
| Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes | Q79819381 | ||
| Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk | Q80259660 | ||
| Proinflammatory response of human leukemic cells to dsRNA transfection linked to activation of dendritic cells | Q80382738 | ||
| Toll-like receptors (TLRs) are expressed by myeloid leukaemia cell lines, but fail to trigger differentiation in response to the respective TLR ligands | Q84392005 | ||
| MYD88 Mutations and Response to Ibrutinib in Waldenström's Macroglobulinemia | Q85732520 | ||
| Demand-adapted regulation of early hematopoiesis in infection and inflammation | Q27011458 | ||
| Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes | Q27015288 | ||
| Proinflammatory signaling regulates hematopoietic stem cell emergence. | Q27324011 | ||
| Helical assembly in the MyD88–IRAK4–IRAK2 complex in TLR/IL-1R signalling | Q27661754 | ||
| MYD88 L265P somatic mutation in Waldenström's macroglobulinemia. | Q27851888 | ||
| Ibrutinib in previously treated Waldenström's macroglobulinemia. | Q27853148 | ||
| Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy | Q28067939 | ||
| Different Toll-Like Receptor Expression Patterns in Progression toward Cancer | Q28085163 | ||
| IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway | Q28190704 | ||
| Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling | Q28259810 | ||
| UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes | Q28270473 | ||
| The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9 | Q28292044 | ||
| Oncogenically active MYD88 mutations in human lymphoma | Q28301648 | ||
| Identification of Lps2 as a key transducer of MyD88-independent TIR signalling | Q28587545 | ||
| Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4 | Q28611075 | ||
| Dynamic variation in cycling of hematopoietic stem cells in steady state and inflammation | Q28742707 | ||
| Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia | Q29614659 | ||
| Myelodysplastic syndromes: Contemporary review and how we treat | Q33429195 | ||
| Toll-like receptor alterations in myelodysplastic syndrome | Q33572616 | ||
| Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance | Q33755300 | ||
| Combination therapy targeting toll like receptors 7, 8 and 9 eliminates large established tumors | Q33824623 | ||
| Infection mobilizes hematopoietic stem cells through cooperative NOD-like receptor and Toll-like receptor signaling | Q33857117 | ||
| Toll-Like Receptors and Cancer: MYD88 Mutation and Inflammation. | Q33978723 | ||
| Conversion of danger signals into cytokine signals by hematopoietic stem and progenitor cells for regulation of stress-induced hematopoiesis | Q33993410 | ||
| DAMPening inflammation by modulating TLR signalling | Q34035570 | ||
| Functional diversity of stem and progenitor cells with B-lymphopoietic potential | Q34083743 | ||
| Endothelial cells translate pathogen signals into G-CSF-driven emergency granulopoiesis | Q34106812 | ||
| Toll-like receptor-4 signaling in mantle cell lymphoma: effects on tumor growth and immune evasion | Q34415459 | ||
| Chronic TLR signaling impairs the long-term repopulating potential of hematopoietic stem cells of wild type but not Id1 deficient mice | Q34577180 | ||
| Chronic exposure to a TLR ligand injures hematopoietic stem cells | Q34907233 | ||
| Overexpression of the toll-like receptor (TLR) signaling adaptor MYD88, but lack of genetic mutation, in myelodysplastic syndromes | Q34970662 | ||
| Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype | Q35011883 | ||
| Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment | Q35113561 | ||
| Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer. | Q35197371 | ||
| The role of TLR8 signaling in acute myeloid leukemia differentiation | Q35288072 | ||
| Loss of Tifab, a del(5q) MDS gene, alters hematopoiesis through derepression of Toll-like receptor-TRAF6 signaling | Q35803662 | ||
| The Role of TLR2 in Infection and Immunity | Q35927566 | ||
| Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma | Q36074728 | ||
| Antagonist-mediated down-regulation of Toll-like receptors increases the prevalence of human papillomavirus infection in systemic lupus erythematosus. | Q36245824 | ||
| TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase | Q36259614 | ||
| Differential constitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes, and macrophages | Q36389463 | ||
| TLR agonists: our best frenemy in cancer immunotherapy | Q36850457 | ||
| Toll-like receptors in the brain and their potential roles in neuropathology. | Q36898647 | ||
| Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9 | Q36909178 | ||
| Targeting IRAK1 as a therapeutic approach for myelodysplastic syndrome | Q37011627 | ||
| Toll-like receptors' two-edged sword: when immunity meets apoptosis. | Q37011869 | ||
| Impaired clearance of apoptotic cells leads to HMGB1 release in the bone marrow of patients with myelodysplastic syndromes and induces TLR4-mediated cytokine production. | Q37060644 | ||
| A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma | Q37090435 | ||
| Induction of myelodysplasia by myeloid-derived suppressor cells. | Q37259216 | ||
| Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment | Q37373357 | ||
| Combinations of TLR ligands: a promising approach in cancer immunotherapy | Q37383587 | ||
| Dysfunctional expansion of hematopoietic stem cells and block of myeloid differentiation in lethal sepsis | Q37414700 | ||
| Consequences of the recurrent MYD88(L265P) somatic mutation for B cell tolerance | Q37630211 | ||
| The TAK1-TRAF6 signalling pathway | Q37671306 | ||
| Anticancer function of polyinosinic-polycytidylic acid | Q37798657 | ||
| Inflammatory signals regulate hematopoietic stem cells | Q37828295 | ||
| Toll-Like Receptors (TLRs): The Role in Tumor Progression | Q38014847 | ||
| Pediatric myelodysplastic syndromes: they do exist! | Q38171923 | ||
| The mechanism of action of BCG therapy for bladder cancer--a current perspective | Q38184849 | ||
| TLR Agonists for Cancer Immunotherapy: Tipping the Balance between the Immune Stimulatory and Inhibitory Effects | Q38195599 | ||
| The inflammatory microenvironment in MDS. | Q38348119 | ||
| Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells | Q38507121 | ||
| Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword | Q38878794 | ||
| Heterodimer-specific TLR2 stimulation results in divergent functional outcomes in B-cell precursor acute lymphoblastic leukemia | Q38888128 | ||
| Direct Toll-like receptor-mediated stimulation of hematopoietic stem and progenitor cells occurs in vivo and promotes differentiation toward macrophages | Q39363077 | ||
| Inflammation-induced up-regulation of TLR2 expression in human endothelial cells is independent of differential methylation in the TLR2 promoter CpG island. | Q39504839 | ||
| Systemic TLR2 agonist exposure regulates hematopoietic stem cells via cell-autonomous and cell-non-autonomous mechanisms | Q39675197 | ||
| The TLR1/2 agonist PAM(3)CSK(4) instructs commitment of human hematopoietic stem cells to a myeloid cell fate | Q39819090 | ||
| Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy | Q40010311 | ||
| Human skin endothelial cells can express all 10 TLR genes and respond to respective ligands | Q40058099 | ||
| TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance | Q40165390 | ||
| Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors | Q40289625 | ||
| Toll-like receptors mediate proliferation and survival of multiple myeloma cells | Q40291993 | ||
| TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction | Q40675827 | ||
| MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction | Q41149988 | ||
| Inflammatory signaling regulates hematopoietic stem and progenitor cell emergence in vertebrates | Q41582148 | ||
| A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenström macroglobulinemia. | Q42285217 | ||
| G-CSF regulates hematopoietic stem cell activity, in part, through activation of Toll-like receptor signaling | Q42787187 | ||
| Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. | Q43845859 | ||
| Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma | Q43897803 | ||
| A cell-intrinsic role for TLR2-MYD88 in intestinal and breast epithelia and oncogenesis. | Q45976947 | ||
| The history of Toll-like receptors - redefining innate immunity. | Q46240771 | ||
| STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation. | Q46493365 | ||
| Upregulation of TLR2 expression on G-CSF-mobilized peripheral blood stem cells is responsible for their rapid engraftment after allogeneic hematopoietic stem cell transplantation. | Q53442383 | ||
| The expression of Toll-like receptors in patients with acute myeloid leukemia treated with induction chemotherapy. | Q53627646 | ||
| Expression and function of toll-like receptors in multiple myeloma patients: toll-like receptor ligands promote multiple myeloma cell growth and survival via activation of nuclear factor-kappaB. | Q54419884 | ||
| Expression and function of toll like receptors in chronic lymphocytic leukaemia cells. | Q54505699 | ||
| Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow CD34+ progenitor cells along the myeloid lineage. | Q54575672 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | toll-like receptor | Q408004 |
| P304 | page(s) | 390 | |
| P577 | publication date | 2016-09-28 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | The Role of Toll-Like Receptors in Hematopoietic Malignancies | |
| P478 | volume | 7 |
| Q94547384 | A Dual TLR7/TLR9 Inhibitor HJ901 Inhibits ABC-DLBCL Expressing the MyD88 L265P Mutation |
| Q40246794 | Activation of TLR7 Inhibition of Mycobacterium Tuberculosis Survival by Autophagy in RAW 264.7 Macrophages. |
| Q47106227 | Chemokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigen-specific IgA seropositive population. |
| Q91341088 | Cytokine production in myelofibrosis exhibits differential responsiveness to JAK-STAT, MAP kinase, and NFκB signaling |
| Q92978283 | Depicting the genetic architecture of pediatric cancers through an integrative gene network approach |
| Q64076861 | Dysregulation of Cell Survival in Diffuse Large B Cell Lymphoma: Mechanisms and Therapeutic Targets |
| Q92977777 | Expression of toll-like receptors and their regulatory roles in murine cardiac telocytes |
| Q92127608 | Functional Toll-Like Receptors (TLRs) Are Expressed by a Majority of Primary Human Acute Myeloid Leukemia Cells and Inducibility of the TLR Signaling Pathway Is Associated with a More Favorable Phenotype |
| Q55401366 | Hsp90 Inhibition Reduces TLR5 Surface Expression and NF-κB Activation in Human Myeloid Leukemia THP-1 Cells. |
| Q47116205 | Inflammatory Signaling Pathways in Preleukemic and Leukemic Stem Cells |
| Q49875948 | Loss of toll-like receptor 2 results in accelerated leukemogenesis in the NUP98-HOXD13 mouse model of MDS. |
| Q89909025 | Network Pharmacology-Based Investigation of the System-Level Molecular Mechanisms of the Hematopoietic Activity of Samul-Tang, a Traditional Korean Herbal Formula |
| Q38650702 | Novel Gene and Network Associations Found for Acute Lymphoblastic Leukemia Using Case-Control and Family-Based Studies in Multiethnic Populations |
| Q89776910 | Proliferation through activation: hemophagocytic lymphohistiocytosis in hematologic malignancy |
| Q37690959 | Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways |
| Q48336230 | RNA-binding proteins mind the GAPs. |
| Q48018788 | Regulation of myelopoiesis by proinflammatory cytokines in infectious diseases |
| Q41123286 | Role of Type I and II Interferons in Colorectal Cancer and Melanoma. |
| Q64055264 | Yersinia pestis Exploits Early Activation of MyD88 for Growth in the Lungs during Pneumonic Plague |
Search more.